about
Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancerImmune Cells in Cancer Therapy and Drug DeliveryHeparan Sulfate Proteoglycan Metabolism and the Fate of Grafted TissuesStrategies and Advancements in Harnessing the Immune System for Gastric Cancer ImmunotherapyVaccines for pancreatic cancerImmunotherapy advances for glioblastomaNovel immunotherapeutic strategies of gastric cancer treatmentTrial watch: Dendritic cell-based anticancer therapyRegulatory dendritic cell therapy: from rodents to clinical applicationSize-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitroViral Vaccines and CTL ResponseImmune evasion pathways and the design of dendritic cell-based cancer vaccinesEngulfing tumors with synthetic extracellular matrices for cancer immunotherapyAdenosine 2A receptors in acute kidney injuryDendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge.Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer.Laser vaccine adjuvants. History, progress, and potentialDendritic cells in acute kidney injury: cues from the microenvironment.Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha.Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.Bone marrow-derived dendritic cells pulsed with tumor lysates induce anti-tumor immunity against gastric cancer ex vivoDendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma modelAbrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine.Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gammaRecombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity.Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapiesTumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine.Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses.CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo.Immune tolerance induction by integrating innate and adaptive immune regulators.FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapyThe immunobiology of mushrooms.CD40-activated B cell cancer vaccine improves second clinical remission and survival in privately owned dogs with non-Hodgkin's lymphomaA potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy.Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.Dendritic cells loaded with tumor B cells elicit broad immunity against murine gammaherpesvirus 68 but fail to prevent long-term latencyHuman IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model.
P2860
Q23918376-A1E5F0C4-3503-4C99-AD8A-FD91BDB43075Q26747061-67E990DC-7A4E-40BC-9A62-26AE1DEC9C4EQ26797410-BE93F686-8FFD-4B19-8849-A5878344E35BQ26823515-E2706B0F-07E2-4E7C-A17B-D42CC40EF0B0Q26825850-14ED7A93-9816-486A-9E69-574BA474C375Q26866513-81C28324-EF7B-4334-BD16-7F355FC4DA0AQ27011232-08E74C95-67E8-48B7-8C7C-267E8C437409Q27024047-4EACCF00-465F-4391-A946-8830A1DCCC01Q27025996-ABBA1AA1-8F14-4269-8375-EB64D0B1D7EDQ27334432-FBB35E75-38C2-4827-8717-7DA765C9BDBDQ27491330-C5DBD008-7EF9-47E6-A5B4-40296F53EAC6Q28076556-1A9BF6F5-0758-43E1-958F-450FCB682AC0Q28749647-E9BD0215-D282-4D3C-AB88-D2BC2EFC9894Q30300186-7C645E92-B667-42CE-BA69-957CF80FBECDQ30318566-5299BC8E-DAF0-4429-BA86-EC3029555DA3Q30409053-AC8DF7B6-B8D5-4F48-9294-746735C0B7FBQ30413501-332CF5F8-132A-4E84-9F12-AD5E950FC72CQ30422946-FCE82B5D-BF65-4B50-BB91-A86685358F16Q30436422-9F349D48-328C-4F25-8BD0-D9859B71DF17Q30846001-D2615AA8-3A44-4999-867E-9BEB2EA19D81Q33347561-D8F9264F-D19A-4305-BA59-759079B0F687Q33384384-E6D7CBB1-CEBB-448C-81D2-EA5755539C73Q33393205-1BD6241D-0C6B-47A9-BF1E-9FE11DA4A737Q33614807-C5A4B874-8B6B-40FE-B052-9EC2C17FE14AQ33622752-9EDF717C-04BB-43BD-A6AC-D7F23141E2E5Q33705361-C8F39DFF-4882-4549-98DD-96FE311B80EDQ33713903-607D1A50-AAE9-49A6-9F29-D4FB447770F8Q33738902-DB78176A-9CF5-4804-9637-1865F8561DBDQ33763653-24F871DF-F6F0-453A-BAFA-B06436406C78Q33767127-A54AE8B9-4A9F-4D32-8D0D-A51945CC52EAQ33786246-3E5C11DB-F186-4E0C-9DDC-78173A0821E7Q33864097-86C153C6-FD9A-40E8-B8F5-2FF8A5CB0485Q33907609-2A3F8A7A-B9E3-4F01-BBB9-2D3362DC8BA3Q33951651-F7E84E72-AAE8-4895-AB8D-D867272C467EQ34010091-10C1FBBA-5C6C-450E-8A77-87D2638140BBQ34014497-BCD9BE64-9090-4541-B4DF-ECE281B7CE8EQ34015759-E510C551-9D54-458F-9BE3-02091C0C5D87Q34020065-7B10AAAE-A11A-46EE-A93A-CBE5E1319349Q34055365-E7DFB17B-E5CF-4048-86CF-0299F02EE2A6Q34152633-714DE3E8-95B3-4B8C-B485-FC1A613CCB85
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
DC-based cancer vaccines.
@ast
DC-based cancer vaccines.
@en
type
label
DC-based cancer vaccines.
@ast
DC-based cancer vaccines.
@en
prefLabel
DC-based cancer vaccines.
@ast
DC-based cancer vaccines.
@en
P2860
P356
P1476
DC-based cancer vaccines.
@en
P2093
Eli Gilboa
P2860
P304
P356
10.1172/JCI31205
P407
P577
2007-05-01T00:00:00Z